Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer

Fig. 1

Expression and prognosis value of FTO in STAD. A FTO expression in STAD based on Sample types (Normal and Primary tumor). B FTO expression in STAD based on nodal metastasis status (Normal, N0, N1, N2, N3). C FTO expression in STAD based on tumor grade (Normal, Grade1, Grade2, Grade3). D FTO expression in STAD based on individual cancer stages (Normal, Stage1, Stage 2, Stage 3, Stage4). E Effect of FTO expression level on STAD patients’ survival. F Survival curves of overall survival and disease-free survival of FTO high expression and FTO low expression of STAD

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us